Classification: ANTIVIRAL
ACTION & THERAPEUTIC EFFECT
Pyrimidine nucleoside that appears to inhibit
viral DNA synthesis and viral replication. Active against herpes
simplex virus (HSV) types 1
and 2, vaccinia virus, and certain strains
of adenovirus.
Topically to eyes for treatment of primary
keratoconjunctivitis and recurring epithelial keratitis caused by herpes
simplex virus types 1 and 2. Also for other herpetic ophthalmic infections
including stromal keratitis, uveitis, and for infections caused by vaccinia and
Adenovirus, but clinical effectiveness has not been
established.
Dry eye syndrome; pregnancy (category C); children
younger than 6 y.
|
Nursing Implications For Trifluridine Viroptic |
Related for Nursing Implications and Drugs Guide Information
- Nursing Implications for Trihexyphenidyl Hydrochloride
- Nursing Implications of Trimethobenzamide Hydrochloride Tigan
- Nursing Implications of Trimethoprim Primsol
- Nursing Implications of Trimipramine Maleate
- Nursing Implications for Trelstar Depot (Triptorelin pamoate)
- Nursing Implications for Sanctura Trospium Chloride
Adult: Ophthalmic 1 drop 1% ophthalmic solution into affected eye q2h during waking
hours until healing (reepithelialization) has occurred (max: 9 drops/day); when
healing appears to be complete, dosage reduced to 1 drop q4h during waking
hours for an additional 7 days (max: 5 drops/day); continuous administration
beyond 21 days not recommended
- Wait several minutes between applications when
used concurrently with other eye drops.
- Store refrigerated at 2°–8° C (36°–46° F) unless
otherwise directed.
Special Senses: Mild transient burning or stinging,
mild irritation of conjunctiva or cornea, photophobia, edema of eyelids and cornea, punctual occlusion,
superficial punctate keratopathy, epithelial
keratopathy, stromal edema, keratitis sicca, hyperemia, increased intraocular pressure.
Absorption: Following topical application to eye,
trifluridine penetrates cornea and aqueous humor (inflammation enhances penetration). Systemic absorption
does not appear to be significant.
Assessment & Drug Effects
- Expect epithelial eye infections to respond to
therapy within 2–7 days, with complete healing occurring in 1–2 wk.
Patient & Family Education
- Inform prescriber of progress and keep follow-up
appointments. Herpetic eye infections have a tendency to recur and can lead to
corneal damage if not adequately treated.
Artikel keren lainnya:
Belum ada tanggapan untuk "Nursing Implications For Trifluridine Viroptic"
Post a Comment